CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Novo Nordisk A/S - share repurchase programme

Neutral
AI Analysis

Summary

Novo Nordisk initiated a share repurchase programme on 6 May 2026 as part of a DKK 15 billion buyback program to be executed over a 12-month period beginning 4 February 2026, in compliance with MAR and Safe Harbour Rules.

Importance:2/10
Sentiment:
0.00
share repurchasecapital allocationshareholder return
Related Companies

Read the original article

Published by GlobeNewswire Pharma on July 20, 2026 12:32 PM

Read Original